Literature DB >> 9003476

Serum erythropoietin levels in patients with sepsis and septic shock.

J Abel1, N Spannbrucker, J Fandrey, W Jelkmann.   

Abstract

The role of the immune system in the control of the production of erythropoietin is still poorly understood. Herein, the levels of circulating immunoreactive erythropoietin, tumour necrosis factor alpha, interleukin-1 beta and interleukin-6 were determined in 10 septic patients for up to 4 d following the admission to an internal intensive care unit. The data show that the production of erythropoietin was not suppressed despite an increase in the levels of proinflammatory cytokines. Circulating erythropoietin and interleukin-6 greatly increased in the 6 nonsurviving patients. The pattern of the serum erythropoietin level in the nonsurvivors resembled that of acute phase proteins and was independent of the blood haemoglobin concentration. Similar to interleukin 6, abnormally high serum erythropoietin levels appear to be a negative prognostic indicator in patients suffering from septic shock.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9003476     DOI: 10.1111/j.1600-0609.1996.tb01393.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  8 in total

1.  Variability in the immunodetection of His-tagged recombinant proteins.

Authors:  Natasa Debeljak; Laurie Feldman; Kerry L Davis; Radovan Komel; Arthur J Sytkowski
Journal:  Anal Biochem       Date:  2006-11-01       Impact factor: 3.365

Review 2.  Erythropoetin as a novel agent with pleiotropic effects against acute lung injury.

Authors:  Sotirios Kakavas; Theano Demestiha; Panagiotis Vasileiou; Theodoros Xanthos
Journal:  Eur J Clin Pharmacol       Date:  2010-11-11       Impact factor: 2.953

Review 3.  Impact of erythropoietin on intensive care unit patients.

Authors:  Ines Jelkmann; Wolfgang Jelkmann
Journal:  Transfus Med Hemother       Date:  2013-08-16       Impact factor: 3.747

Review 4.  Bench to bedside: A role for erythropoietin in sepsis.

Authors:  Andrew P Walden; J Duncan Young; Edward Sharples
Journal:  Crit Care       Date:  2010-08-06       Impact factor: 9.097

Review 5.  Is There a Role for Hematopoietic Growth Factors During Sepsis?

Authors:  Benjamin G Chousterman; Marine Arnaud
Journal:  Front Immunol       Date:  2018-06-21       Impact factor: 7.561

6.  Repurposing of High-Dose Erythropoietin as a Potential Drug Attenuates Sepsis in Preconditioning Renal Injury.

Authors:  Wiwat Chancharoenthana; Kanyarat Udompronpitak; Yolradee Manochantr; Piyawat Kantagowit; Ponthakorn Kaewkanha; Jiraporn Issara-Amphorn; Asada Leelahavanichkul
Journal:  Cells       Date:  2021-11-12       Impact factor: 6.600

7.  Erythropoietin mimics the acute phase response in critical illness.

Authors:  John Michael Elliot; Tanit Virankabutra; Stephen Jones; Surasak Tanudsintum; Graham Lipkin; Susan Todd; Julian Bion
Journal:  Crit Care       Date:  2003-04-24       Impact factor: 9.097

8.  Erythropoietin and renin as biological markers in critically ill patients.

Authors:  Fabienne Tamion; Véronique Le Cam-Duchez; Jean-François Menard; Christophe Girault; Antoine Coquerel; Guy Bonmarchand
Journal:  Crit Care       Date:  2004-08-09       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.